Zobrazeno 1 - 10
of 857
pro vyhledávání: '"Giovanni Pellacani"'
Autor:
Piergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, Laura Atzori, Anna Balato, Federico Bardazzi, Luca Bianchi, Angelo Cattaneo, Andrea Chiricozzi, Maurizio Congedo, Maria Concetta Fargnoli, Claudia Giofrè, Paolo Gisondi, Claudio Guarneri, Serena Lembo, Francesco Loconsole, Giampiero Mazzocchetti, Santo Raffaele Mercuri, Pietro Morrone, Anna Maria Offidani, Giovanni Palazzo, Aurora Parodi, Giovanni Pellacani, Stefano Piaserico, Concetta Potenza, Francesca Prignano, Marco Romanelli, Paola Savoia, Luca Stingeni, Massimo Travaglini, Emanuele Trovato, Marina Venturini, Leonardo Zichichi, Antonio Costanzo
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 10, Pp 2739-2757 (2024)
Abstract Psoriasis is a chronic, immune-mediated, inflammatory skin disease, associated with multiple comorbidities and psychological and psychiatric disorders. The quality of life of patients with this disease is severely compromised, especially in
Externí odkaz:
https://doaj.org/article/b2dc3d0128c14cb0bc54ca76a47a5f99
Autor:
Carmen Cantisani, Federica Trovato, Luca Gargano, Antonio Di Guardo, Alexandru Bâja Vasile, Emanuele Rovaldi, Giulia Azzella, Iolanda Speranza, Giuseppe Soda, Michela Roberto, Tiziana Lettera, Giovanni Pellacani
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 687-692 (2024)
Abstract Breast cancer represents the most common malignancy in women worldwide. In most cases, metastasis is the leading cause of mortality. Early diagnosis is still challenging despite standardised, government‐led screening programs, but is cruci
Externí odkaz:
https://doaj.org/article/bb4c8b238e0746239cac7ec2f4633d38
Autor:
Stefania Guida, Shaniko Kaleci, Renato Rossi, Giulia Radi, Elisa Molinelli, Giovanni Pellacani, Elisa Cinotti, Italian Optical Super-High Magnification Dermoscopy Group
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/26fce25db2514f5d9b69aa651db83689
Publikováno v:
Surgeries, Vol 5, Iss 2, Pp 367-376 (2024)
This study explores the innovative use of CO2 laser technology in frenuloplasty, a significant shift from classic methods like scalpel surgery or electrocautery towards a minimally invasive approach. The research involved 15 patients aged 25 to 50, u
Externí odkaz:
https://doaj.org/article/81febb59fb70423caad6cc28618adc98
Autor:
Sarah Alulis, Nicoletta Bernardini, Martina Burlando, Antonio Costanzo, Pier Cesare Francesa Morel, Paolo Gisondi, Francesco Loconsole, Matteo Megna, Giovanni Pellacani, Stefano Piaserico, Francesca Prignano, Ottavio Secchi, Nevena Skroza, Fareen Hassan
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1273-1291 (2024)
Abstract Introduction There are several treatment options for plaque psoriasis (PsO), but uncertainty remains around the optimal sequencing of treatments. The aims of this study were to investigate how adopting a best-treatment-first treatment sequen
Externí odkaz:
https://doaj.org/article/ff75665eae034ad7a5181488eb2829bc
Autor:
Annunziata Dattola, Nicoletta Bernardini, Francesca Svara, Anna Balato, Giacomo Caldarola, Domenico D’Amico, Clara De Simone, Eugenia Veronica Di Brizzi, Maria Esposito, Claudia Giofrè, Domenico Giordano, Claudio Guarneri, Francesco Loconsole, Viviana Lora, Gaia Moretta, Diego Orsini, Severino Persechino, Concetta Potenza, Simone Ragonesi, Giovanni Pellacani, Ketty Peris, Maria Concetta Fargnoli, Antonio Giovanni Richetta
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Introduction: Psoriasis is a chronic immune-mediated disease that can be challenging to treat, especially in patients with severe disease or high body weight. Tildrakizumab is a monoclonal antibody which inhibits IL-23, approved for moderate-to-sever
Externí odkaz:
https://doaj.org/article/0025053498fe49b2841bd41e99bc2742
Autor:
Diego Orsini, Giacomo Caldarola, Annunziata Dattola, Elena Campione, Nicoletta Bernardini, Pasquale Frascione, Clara De Simone, Antonio G. Richetta, Marco Galluzzo, Nevena Skroza, Chiara Assorgi, Emanuele Amore, Gennaro M. Falco, Ruslana Gaeta Shumak, Fabio Artosi, Giulia Maretti, Concetta Potenza, Luca Bianchi, Giovanni Pellacani, Ketty Peris, Claudio Bonifati, Dario Graceffa
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Purpose of the article: Interleukin-23 inhibitors, such as tildrakizumab, have emerged as safe and effective options for the management of psoriasis. Yet their efficacy in elderly patients (aged 65 years or more), particularly in those with difficult
Externí odkaz:
https://doaj.org/article/6ed0bed7541c4a9084145e7ddf8bf2a1
Autor:
Claudio Conforti, Luca Ambrosio, Chiara Retrosi, Carmen Cantisani, Giovanni Di Lella, Luca Fania, Roberta Rotunno, Iris Zalaudek, Giovanni Pellacani
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss S1 (2024)
Actinic keratosis (AK) is one of the most frequent tumors of the skin; the diagnosis is basically clinical although in some cases it may be difficult to distinguish it from other keratinocytic or even melanocytic neoplasms when it presents in pigment
Externí odkaz:
https://doaj.org/article/46d2ef5ef52b4abd9e6fdbe093957c99
Autor:
Teresa Grieco, Elisa Moliterni, Giovanni Paolino, Camilla Chello, Alvise Sernicola, Colin Gerard Egan, Fabrizio Nannipieri, Santina Battaglia, Marina Accoto, Erika Tirotta, Silvia Trasciatti, Silvano Bonaretti, Simona Nencioni, Elena Biasci, Giovanni Pellacani, Stefano Calvieri
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024)
Background: Few studies have explored the intricate connections between vitamin D receptor (VDR) gene polymorphisms, VDR, tight junction (TJ) protein expression and clinical features of atopic dermatitis (AD). Methods: From 43 adult AD patients, VD
Externí odkaz:
https://doaj.org/article/f5c7a7e7b4c34d579d8dbc16f0dbea9e
Autor:
Annunziata Dattola, Martina Tolone, Emanuele Amore, Luigi Bennardo, Simone Amato, Teresa Grieco, Antonio Giovanni Richetta, Giovanni Pellacani, Nevena Skroza, Steven Paul Nisticò
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024)
Introduction: The advent of biotechnological drugs has significantly changed the management of atopic dermatitis (AD) and the approach to the moderate-to-severe form of this chronic relapsing disease. Objectives: The aim of our review is to summari
Externí odkaz:
https://doaj.org/article/ca7ce1e99b07470987c1f55e9810114c